Impact

  1. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage

    Silke Gillessen Sommer (Participant)

    Impact: Health impacts

  2. Implementation of TIL therapy in Ovarian Cancer

    Richard Edmondson (Participant), Gordon Jayson (Participant)

    Impact: Health impacts

  3. A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation

    Peter Hoskin (Participant), Angela R. McLean (Participant), Ella K Adlen (Participant), Elisabeth Cardis (Participant), Dudley T Goodhead (Participant), Mats Harms-Ringdahl (Participant), JH. Hendry (Participant), Penny A. Jeggo (Participant), DJC Mackay (Participant), Colin R Muirhead (Participant), J Shepherd (Participant), R. E. Shore (Participant), GA Thomas (Participant), R Wakeford (Participant), H. Charles J Godfray (Participant)

    Impact

  4. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

    Peter Hoskin (Participant), Carl Salembier (Participant), Geert Villeirs (Participant), B De Bari (Participant), Bradley R Pieters (Participant), Marco van Vulpen (Participant), V Khoo (Participant), A Henry (Participant), Alberto Bossi (Participant), Gert De Meerleer (Participant), Valérie Fonteyne (Participant)

    Impact

  5. GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update.

    Peter Hoskin (Participant), A. Colombo (Participant), A Henry (Participant), P Niehoff (Participant), Taran Paulsen Hellebust (Participant), Frank-Andre Siebert (Participant), G Kovacs (Participant)

    Impact

Previous 1 2 3 4 5 6 7 8 ...35 Next